% | $
Quotes you view appear here for quick access.

DARA Biosciences, Inc. Message Board

  • biotuesday biotuesday Nov 12, 2013 8:01 AM Flag

    BioTuesdays: DARA’s sales team goes on a Mission

    November 12, 2013 by leonardzehr · Leave a Comment

    A new sales and marketing venture with a unit of Mission Pharmacal gives DARA BioSciences (NASDAQ:DARA) a formidable leg up in the oncology supportive care sector to address ongoing areas of medical need.

    A 20-person national sales team contracted from Mission’s Alamo Pharma Services will promote DARA’s products, including Soltamox, Gelclair, and Bionect, as well as three Mission products—Ferralet 90 for anemia, BINOSTO for osteoporosis, and Aquoral for chemotherapy/radiation therapy-induced dry mouth. The Alamo sales reps will work under the direction of two DARA sales managers.

    “This dedicated sales force can provide a formidable product portfolio that addresses many of the common challenges and side effects that cancer patients deal with on a daily basis, including oral mucositis, loss of bone density, radiation dermatitis, dry mouth, anemia, and long-term adherence to tamoxifen,” DARA’s CEO and CMO, Dr. David Drutz, says in an interview with BioTuesdays........

    ....See BioTuesdays for rest of this week's feature article...

0.880.00(0.00%)Dec 4 3:59 PMEST